Allen TJ - Search Results

1

Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.

Tikkanen I, Tikkanen T, Cao Z, Allen TJ, Davis BJ, Lassila M, Casley D, Johnston CI, Burrell LM, Cooper ME. Tikkanen I, et al. Among authors: allen tj. J Hypertens. 2002 Apr;20(4):707-14. doi: 10.1097/00004872-200204000-00029. J Hypertens. 2002. PMID: 11910307

2

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.

Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, Kawachi H, Allen TJ, Cooper ME, Jerums G, Osicka TM. Forbes JM, et al. Among authors: allen tj. J Hypertens. 2002 May;20(5):985-92. doi: 10.1097/00004872-200205000-00034. J Hypertens. 2002. PMID: 12011660

3

Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.

Davis BJ, Cao Z, de Gasparo M, Kawachi H, Cooper ME, Allen TJ. Davis BJ, et al. Among authors: allen tj. J Hypertens. 2003 Jan;21(1):209-16. doi: 10.1097/00004872-200301000-00031. J Hypertens. 2003. PMID: 12544453

4

Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.

Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z. Lassila M, et al. Among authors: allen tj. Clin Sci (Lond). 2003 Apr;104(4):341-7. Clin Sci (Lond). 2003. PMID: 12653675

5

Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.

Ma G, Allen TJ, Cooper ME, Cao Z. Ma G, et al. Among authors: allen tj. Kidney Int. 2004 Sep;66(3):1090-8. doi: 10.1111/j.1523-1755.2004.00859.x. Kidney Int. 2004. PMID: 15327403 Free article.

6

Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.

Jandeleit-Dahm K, Lassila M, Davis BJ, Candido R, Johnston CI, Allen TJ, Burrell LM, Cooper ME. Jandeleit-Dahm K, et al. Among authors: allen tj. J Hypertens. 2005 Nov;23(11):2071-82. doi: 10.1097/01.hjh.0000184747.41565.a1. J Hypertens. 2005. PMID: 16208151

7

Eplerenone does not attenuate diabetes-associated atherosclerosis.

Koh PJ, Koitka A, Cooper ME, Allen TJ. Koh PJ, et al. Among authors: allen tj. J Hypertens. 2009 Jul;27(7):1431-8. doi: 10.1097/HJH.0b013e32832bd284. J Hypertens. 2009. PMID: 19381106

8

Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.

Allen TJ, Hulthen UL, Rumble JR, Jasik M, Cooper ME. Allen TJ, et al. J Diabetes Complications. 1995 Oct-Dec;9(4):318-22. doi: 10.1016/1056-8727(95)80031-9. J Diabetes Complications. 1995. PMID: 8573756

9

Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.

Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME. Allen TJ, et al. Diabetes. 1997 Jan;46(1):19-24. doi: 10.2337/diabetes.46.1.19. Diabetes. 1997. PMID: 8971091

10

Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.

Allen TJ, Cao Z, Youssef S, Hulthen UL, Cooper ME. Allen TJ, et al. Diabetes. 1997 Oct;46(10):1612-8. doi: 10.2337/diacare.46.10.1612. Diabetes. 1997. PMID: 9313758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters